Scott Robert Henry Sells 3,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the business’s stock in a transaction on Friday, December 20th. The stock was sold at an average price of $4.64, for a total transaction of $13,920.00. Following the completion of the transaction, the director now owns 144,553 shares in the company, valued at $670,725.92. This represents a 2.03 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

NEXGEL Stock Performance

Shares of NXGL stock opened at $4.74 on Thursday. NEXGEL, Inc. has a 12 month low of $1.84 and a 12 month high of $5.10. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.51 and a quick ratio of 0.93. The firm has a market capitalization of $32.19 million, a P/E ratio of -8.17 and a beta of 0.76. The company’s fifty day moving average price is $3.48 and its two-hundred day moving average price is $2.87.

Hedge Funds Weigh In On NEXGEL

An institutional investor recently raised its position in NEXGEL stock. Northeast Financial Group Inc. boosted its position in NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,848 shares of the company’s stock after buying an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned 0.50% of NEXGEL worth $82,000 at the end of the most recent quarter. 2.21% of the stock is owned by institutional investors and hedge funds.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.